GE Healthcare In Collaboration With GlaxoSmithKline To Develop Improved Data and Information Integration In Drug Discovery
GE Healthcare announced an informatics collaboration agreement with GlaxoSmithKline (GSK) to enable GSK to integrate data from diverse internal and external sources in its drug discovery R&D process
GSK will be able to use geneticXchange’s discoveryHub data and information integration software from GE Healthcare within its R&D areas of Genetics, Discovery and its Centres of Excellence for Drug Discovery and Pre-Clinical Development. This will help GSK to maximize its use of biological, chemical and clinical data generated from its own drug discovery research, and integrate it seamlessly with other third party and public databases.
Under the terms of the agreement, GE Healthcare and geneticXchange will work in collaboration with GSK in the design, development and support of the next generation of discoveryHub technology.
“Effective informatics enable drug researchers to address one of the most difficult challenges in life sciences: transforming data into knowledge,” comments Nick Giannasi, Head of Informatics Solutions at GE Healthcare. “discoveryHub will support GSK in the efficient use of the available biological and clinical data in its drug discovery research. Connecting data sources regardless of location and complexity, discoveryHub provides scientists with access to the data they need in order to make informed decisions quickly.”
About GE Healthcare
GE Healthcare provides transformational medical technologies that are shaping a new age of patient care. GE Healthcare’s expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery and biopharmaceuticals is dedicated to detecting disease earlier and tailoring treatment for individual patients. GE Healthcare offers a broad range of services to improve productivity in healthcare and enable healthcare providers to better diagnose, treat and manage patients with conditions such as cancer, Alzheimer’s and cardiovascular diseases.
GE Healthcare is a $14 billion unit of General Electric Company (NYSE: GE) that is headquartered in the United Kingdom. Worldwide, GE Healthcare employs more than 42,500 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com
